These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19051240)

  • 1. Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol.
    Mohler ER; Shi Y; Moore J; Bantly A; Hamamdzic D; Yoder M; Rader DJ; Putt M; Zhang L; Parmacek M; Wilensky RL
    Cytometry A; 2009 Jan; 75(1):75-82. PubMed ID: 19051240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of statin monotherapy and low-dose statin/ezetimibe on lipoprotein-associated phospholipase A₂.
    Lee SH; Kang SM; Park S; Jang Y; Chung N; Choi D
    Clin Cardiol; 2011 Feb; 34(2):108-12. PubMed ID: 21298654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.
    Pesaro AE; Serrano CV; Katz M; Marti L; Fernandes JL; Parra PR; Campos AH
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):447-52. PubMed ID: 23739650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.
    Vasa M; Fichtlscherer S; Adler K; Aicher A; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2001 Jun; 103(24):2885-90. PubMed ID: 11413075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study.
    Lin LY; Huang CC; Chen JS; Wu TC; Leu HB; Huang PH; Chang TT; Lin SJ; Chen JW
    Cardiovasc Diabetol; 2014 Jul; 13():111. PubMed ID: 25027585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
    Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
    J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
    Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
    Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy.
    Schmidt-Lucke C; Fichtlscherer S; Rössig L; Kämper U; Dimmeler S
    Atherosclerosis; 2010 Jul; 211(1):249-54. PubMed ID: 20211468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease.
    Satoh M; Minami Y; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2009 May; 116(11):827-35. PubMed ID: 19090788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
    Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats.
    Wang B; Sun L; Tian Y; Li Z; Wei H; Wang D; Yang Z; Chen J; Zhang J; Jiang R
    J Neurol Sci; 2012 Aug; 319(1-2):117-23. PubMed ID: 22658532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study.
    Adel A; Abdel-Salam Z; Nammas W
    J Clin Hypertens (Greenwich); 2010 Oct; 12(10):820-5. PubMed ID: 21029347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease.
    Minami Y; Satoh M; Maesawa C; Takahashi Y; Tabuchi T; Itoh T; Nakamura M
    Eur J Clin Invest; 2009 May; 39(5):359-67. PubMed ID: 19371267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK; Watts GF; Chan DC; Stanton K
    Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy.
    Huang B; Cheng Y; Xie Q; Lin G; Wu Y; Feng Y; Gao J; Xu D
    Clin Cardiol; 2012 Feb; 35(2):125-30. PubMed ID: 22271072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Ueno Y; Onoda S; Nagase A; Ohira T; Nakano N; Satonaka H
    Clin Exp Nephrol; 2014 Oct; 18(5):704-10. PubMed ID: 24198051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.